Two Sigma Securities, LLC Novo Cure LTD Transaction History

Two Sigma Securities, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $88,393 - $179,701	-7,472 Reduced 24.75%	22,721 $389,000
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $178,413 - $248,370	-14,365 Reduced 32.24%	30,193 $471,000
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $277,326 - $393,190	24,917 Added 126.86%	44,558 $665,000
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $317,202 - $831,796	19,641 New	19,641 $317,000
Q2 2022 Aug 15, 2022	SELL	$56.6 - $89.9 $761,892 - $1.21 Million	-13,461 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$60.15 - $84.52 $809,679 - $1.14 Million	13,461 New	13,461 $1.12 Million
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $538,266 - $903,401	-9,435 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $644,410 - $885,003	9,435 New	9,435 $795,000

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.04B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.